Jong M. Kim
Cheongju-si, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Effectiveness of Molnupiravir Treatment in Patients with COVID-19 in Korea: A Propensity Score Matched Study.
Journal: Infection & chemotherapy
Published: September 13, 2023
Evaluation of COVID-19 vaccine effectiveness in different high-risk facility types during a period of Delta variant dominance in the Republic of Korea: a cross-sectional study.
Journal: Osong public health and research perspectives
Published: July 05, 2023
Effectiveness of Paxlovid, an Oral Antiviral Drug, Against the Omicron BA.5 Variant in Korea: Severe Progression and Death Between July and November 2022.
Journal: Journal of Korean medical science
Published: February 14, 2023
Early countermeasures to COVID-19 at long-term care facilities in Gwangju Metropolitan City, Republic of Korea.
Journal: Osong public health and research perspectives
Published: November 07, 2022
Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021.
Journal: Emerging infectious diseases
Published: February 16, 2022
Importation and Transmission of SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern in Korea, November 2021.
Journal: Journal of Korean medical science
Published: December 15, 2021
SARS-CoV-2 Delta Variant Breakthrough Infection and Onward Secondary Transmission in Household.
Journal: Journal of Korean medical science
Published: November 11, 2021
Fas-associated factor 1 promotes in neurofibrillary tangle-mediated cell death of basal forebrain cholinergic neurons in P301L transgenic mice.
Journal: Neuroreport
Published: July 13, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026